Primary Catalyst Driving Hereditary Genetic Testing Market Evolution in 2025: Growing Cancer Incidence Spurs Expansion Of Genetic Testing Services Driver

What industry-specific factors are fueling the growth of the hereditary genetic testing market?
The anticipated rise in cancer occurrences is likely to fuel the expansion of the hereditary genetic testing market. Cancer is characterized by abnormal cell growth, leading to a collection of diseases that can metastasize or spread to other body areas. The increasing cancer rates are due to various factors like aging populations, lifestyle modifications, environmental pollution, genetic vulnerabilities, and advanced diagnostic methods. Hereditary genetic testing plays a crucial role in cancer prevention by identifying genetic mutations linked to increased risk, thereby facilitating early monitoring and focused prevention efforts. For example, as per the Australian Institute of Health and Welfare, a government agency in Australia, the reported cancer cases increased from 156,781 in 2021 to 160,570 in 2022 in Australia. Consequently, the rising cancer prevalence contributes significantly to the hereditary genetic testing market's growth.

Get Your Hereditary Genetic Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/hereditary-genetic-testing-global-market-report

What Is the projected market size and growth rate for the hereditary genetic testing market?
The market size for hereditary genetic testing has witnessed rapid expansion in the recent past. Projected growth from $21.47 billion in 2024 to $23.88 billion in 2025 is expected, with a compound annual growth rate (CAGR) of 11.3%. This growth during the historical period is primarily due to an increase in the occurrence of genetic diseases, advancements in healthcare informatics, the rise in telemedicine, more awareness campaigns, and an increasing number of platforms for genetic testing.

The market for hereditary genetic testing is projected to experience swift expansion in the coming years, hitting a size of $36.23 billion by 2029, with a compound annual growth rate (CAGR) of 11.0%. The anticipated growth during this forecasted timeframe can be linked to factors such as an uptick in cancer rates, an increase in genetic disorders, a heightened demand for diagnostic procedures, a shift towards personalized medicine, and a rise in clinical trials. Key trends anticipated during this period encompass advancements in technology, whole-genome sequencing, the incorporation of genetic data, personalized health care, and non-invasive prenatal screening.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20559&type=smp

What new trends are reshaping the hereditary genetic testing market and its opportunities?
Major corporations in the hereditary genetic testing market are homing in on the development of sophisticated genomic remedies, such as multi-cancer multigene panels to bolster early identification and tailored treatment possibilities. These panels are diagnostic aids that simultaneously scrutinize various genes to identify genetic mutations related to diverse cancer types, facilitating swift diagnosis and customized treatment. For example, Exact Sciences Corporation, an American company specializing in cancer screening and diagnostic tests, unveiled the Riskguard hereditary cancer test in February 2024. Employing a straightforward blood or saliva sample, the Riskguard test provides an individualized gene-specific and familial cancer risk report covering 10 prevalent cancers. This test assists in comprehending cancer risk, formulating screening and treatment proposals, and assessing risks within the family. Additionally, it aids in customising treatment for patients already identified as having cancer and boosts risk stratification for individuals with cancer in their family history by pinpointing actionable gene variants.

What major market segments define the scope and growth of the hereditary genetic testing market?
The hereditary genetic testing market covered in this report is segmented -

1) By Type: Predictive And Presymptomatic Testing, Carrier Testing, Prenatal And Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Other Types
2) By Technology: Cytogenetic Testing, Biochemical Testing, Molecular Testing
3) By Clinical Application: Cancer Genetic Testing, Cardiovascular Genetic Testing, Neurological Genetic Testing, Rare Diseases Genetic Testing
4) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Direct To Consumer (DTC) Genetic Testing Companies

Subsegments:
1) By Predictive and Presymptomatic Testing: Genetic Testing For Disease Risk Prediction, Testing For Inherited Cancer Risks, Cardiovascular Disease Risk Testing, Neurodegenerative Disease Risk Testing
2) By Carrier Testing: Testing For Inherited Genetic Disorders, Genetic Screening For Autosomal Recessive Diseases, Testing For Carrier Status Of Inherited Conditions
3) By Prenatal and Newborn Testing: Non-Invasive Prenatal Testing (NIPT), Amniocentesis and Chorionic Villus Sampling (CVS), Newborn Screening For Genetic Disorders, Preconception Genetic Screening
4) By Diagnostic Testing: Genetic Testing For Confirming Suspected Genetic Disorders, Testing For Inherited Syndromes and Congenital Diseases, Diagnostic Testing For Cancer and Tumor Profiling
5) By Pharmacogenomic Testing: Genetic Testing For Drug Response And Efficacy, Testing For Drug Sensitivities and Side Effects, Personalized Medicine and Treatment Optimization
6) By Other Types: Genetic Testing For Wellness And Lifestyle, Genetic Testing For Ancestry And Genealogy, Research-Oriented Genetic Testing

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20559

Which region dominates the hereditary genetic testing market?
North America was the largest region in the hereditary genetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the hereditary genetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the hereditary genetic testing industry growth?
Major companies operating in the hereditary genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Amgen Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Agilent Technologies Inc., Hologic Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Fulgent Genetics Inc., BioReference Laboratories Inc., BGI Group, Invitae Corporation, NeoGenomics Laboratories Inc., 23andMe Inc., MyHeritage Ltd., Color Health Inc., MedGenome Inc., SOPHiA GENETICS SA, Devyser AB, Mapmygenome India Ltd., Igenomix S.L.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20559&type=smp

What Is Covered In The Hereditary Genetic Testing Global Market Report?

•Market Size Forecast: Examine the hereditary genetic testing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the hereditary genetic testing market for a structured understanding.
•Key Players Overview: Analyze major players in the hereditary genetic testing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the hereditary genetic testing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the hereditary genetic testing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the hereditary genetic testing market.
•Industry Challenges: Identify potential risks and obstacles affecting the hereditary genetic testing market.
•Competitive Landscape: Review strategic developments in the hereditary genetic testing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.